Morabito Christopher

Chief Medical OfficerAstria Therapeutics, Inc. (ATXS) · full profile →Form 4 · filed Jan 30, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$111K
Net Open-Market Flow
-$111K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 29, 2024Sell(S)9K$11.15$103K0
Jan 29, 2024Option exercise(M)9K$3.87$36K9K
Jan 26, 2024Option exercise(M)800$3.87$3K800
Jan 26, 2024Sell(S)800$11.02$9K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 29, 2024Option exercise(M)9K$090K
Jan 26, 2024Option exercise(M)800$099K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-008327) within minutes of acceptance. Every field above traces to the original document. Verify it directly: